Virus Diseases: all 927 studies
Page 4 of 10. Open to participants first (112), then studies with results posted, then the rest; newest registration first within each.
- Human Neutrophil Lipocalin as an Aid in the Diagnosis of Bacterial Infection in the Emergency DepartmentCompletedNCT07796945
- Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 PatientsActive, not recruitingNCT07709637Phase 1
- Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.CompletedNCT07692607Not applicable
- Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 PatientsCompletedNCT07690943Not applicable
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy AdultsActive, not recruitingNCT07496450Phase 3
- Viral Infections of the Central Nervous System: Diagnosis and Clinical OutcomeActive, not recruitingNCT07358117
- A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19CompletedNCT07222384Phase 3
- AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile IllnessCompletedNCT07205575
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and AboveCompletedNCT07204964Phase 2
- Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMGCompletedNCT07134725Phase 1/2
- A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and OlderActive, not recruitingNCT07128121Phase 2
- A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and OlderCompletedNCT07121192Phase 2
- A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of AgeCompletedNCT07117487Phase 3
- A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing FormulationsCompletedNCT07089706Phase 4
- RSV Antibiotic Drivers And Resource-useCompletedNCT06977971
- Profiling Vulnerability and Resilience for Mental Illness Following Viral InfectionsActive, not recruitingNCT06945627
- A Study of AK0529 in Adults Patients Hospitalized With RSV InfectionCompletedNCT06942299Phase 2
- Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older AdultsCompletedNCT06890429Phase 2
- Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in ChildrenActive, not recruitingNCT06852846Not applicable
- Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult MalesCompletedNCT06841926Phase 1
- Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TAActive, not recruitingNCT06838780
- Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized AdultsCompletedNCT06779175
- Molecular Panel Evaluation for Diagnosis of Infections of the Central Nervosous SystemCompletedNCT06720519
- A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and AboveActive, not recruitingNCT06645665Phase 1
- Hepatitis E Virus Infection in Oncological PatientsCompletedNCT06631560Not applicable
- Phase I Clinical Trial of Quadrivalent Influenza Virus Split VaccineActive, not recruitingNCT06622590Phase 1
- Development and Validation of (Bio)Sensors for the Identification of PathogensCompletedNCT06548841
- Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus InfectionCompletedNCT06544551Phase 3
- Single Dose Texas 2017 (H3N2) Challenge StudyCompletedNCT06476275Phase 1
- Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric CohortsCompletedNCT06379061
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsCompletedNCT06375512Phase 1
- Evaluating the Human Immune Response to the JYNNEOS VaccineActive, not recruitingNCT06366672Early Phase 1
- ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus InfectionCompletedNCT06342921Phase 2/3
- Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGEActive, not recruitingNCT06333704
- A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus InfectionCompletedNCT06311734Phase 1
- Study of Safety and Efficacy of the Drug Cycloferone in Patients with Acute Respiratory Viral InfectionCompletedNCT06286254
- Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)Active, not recruitingNCT06271655Not applicable
- Oral Ivermectin for Chikungunya Viral InfectionCompletedNCT06259383Phase 3
- Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral InfectionsCompletedNCT06207929
- A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)Active, not recruitingNCT06189053
- Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and InfluenzaCompletedNCT06183229Phase 3
- Effects of LiveSpo X-SECRET in SupportiveTreatment of VaginitisCompletedNCT06165354Not applicable
- Xofluza-Wearables Feasibility-StudyCompletedNCT06161454Phase 4
- A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus InfectionTerminatedNCT06159062Phase 1
- RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionCompletedNCT06149494Phase 2
- A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated MothersCompletedNCT06143046Phase 2
- Post-marketing Safety of Elasomeran/Davesomeran and AndusomeranCompletedNCT06130345
- Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 DiseaseCompletedNCT06113757Not applicable
- A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 VaccineCompletedNCT06113692
- Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents with InfluenzaCompletedNCT06099873Phase 3
- A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsCompletedNCT06067230Phase 3
- Microbes and Respiratory IllnessesCompletedNCT06059027
- A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy AdultsCompletedNCT05972174Phase 1/2
- Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 YearsCompletedNCT05970744Phase 1
- Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy AdultsCompletedNCT05968989Phase 1
- Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and ToddlersCompletedNCT05964582
- Transmission of Respiratory Viruses in Households in The Gambia: a Longitudinal Cohort Study (TransVIR)Active, not recruitingNCT05952336
- Identifying Predictors Of Response To Mepolizumab In CRSwNPActive, not recruitingNCT05902325Phase 4
- Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDROCompletedNCT05897801
- Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in AdultsCompletedNCT05875961Phase 1
- Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in AdultsCompletedNCT05874713Phase 2
- Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza VaccineCompletedNCT05869201Phase 2/3
- Viral and Epigenetic Influences in CRSwNPActive, not recruitingNCT05857228
- The Technical and Operational Performance of the QuidelOrtho Savanna RVP4 AnalyzerCompletedNCT05846360
- Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH PatientsStatus unknownNCT05841342
- A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsActive, not recruitingNCT05831111Phase 1
- Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)Active, not recruitingNCT05797246Phase 2
- Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational StudyCompletedNCT05794412
- iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female SubjectsTerminatedNCT05740280Phase 1
- Anal Fissure Among Survivors of COVID-19 Virus Infection.CompletedNCT05736926
- Evaluation of Safety and Immunogenicity of rVSVΔG-SEBOV-GP Vaccine in Adults With Good General HealthCompletedNCT05724472Phase 1
- Follow-up of the Nasal Microbiome and Viral Infections in Newborns Hospitalised in Neonatology.CompletedNCT05717283Not applicable
- Nosocomial Influenza Surveillance of 2022 - 2027 Seasonal PeriodWithdrawnNCT05712759
- Medicine-induced Cardiac Hemodialysis on COVID-19CompletedNCT05711810Phase 4
- MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)WithdrawnNCT05700734Phase 1
- Coronavirus Infection (COVID-19) and Radical Surgery in Patients With Early-stage Lung CancerActive, not recruitingNCT05684549
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.Active, not recruitingNCT05683457Phase 2
- COMPArative Study of the Consequence on innaTe Immune Response du to Bacterial or Viral Infection in Patients Admitted to Intensive Care UnitActive, not recruitingNCT05671159Not applicable
- Development of a Self-collection Device for Cervical Cancer ScreeningActive, not recruitingNCT05669911Not applicable
- A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe IllnessCompletedNCT05661604
- Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled TrialStatus unknownNCT05651815Not applicable
- Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in SwedenCompletedNCT05622331
- Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)CompletedNCT05620953
- Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human SubjectsStatus unknownNCT05619770Phase 1
- Xylitol Based Nasal Spray for COVID-19 TreatmentStatus unknownNCT05618483Not applicable
- Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUSStatus unknownNCT05618275
- Post-COVID-19 Monitoring in Routine Health Insurance Data With Focus on Autoimmune Diseases (POINTED-AD)CompletedNCT05606198
- Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.Status unknownNCT05568693Not applicable
- Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted VolunteersCompletedNCT05558462Not applicable
- A Dose Finding Study of VN-0200CompletedNCT05547087Phase 2
- A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory InfectionsCompletedNCT05544916Phase 3
- Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney TransplantationTerminatedNCT05511779Phase 2
- T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell TransplantationCompletedNCT05471661Phase 1/2
- Registry for Hemoperfusion of Covid-19 ICU PatientsCompletedNCT05470907
- Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter StudyCompletedNCT05452187
- Immunogenicity and Safety of Co-immunization With Cecolin and HecolinStatus unknownNCT05415345Phase 4
- A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus InfectionCompletedNCT05414981Phase 1
- Pharmacokinetics and Bioequivalence of Molnupiravir, 200 mg Capsules and Lagevrio, 200 mg Capsules in Healthy VolunteersCompletedNCT05412173Not applicable
- A Study of Modified mRNA Vaccines in Healthy AdultsCompletedNCT05397223Phase 1
- Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)Status unknownNCT05394623